世界のアレルギー性鼻炎治療薬市場予測:抗ヒスタミン剤、コルチコステロイド、免疫治療、ワクチン...市場調査レポートについてご紹介

【英文タイトル】ALLERGIC RHINITIS DRUGS MARKET FORECAST 2014-2024
Future Prospects for Companies in Antihistamines, Corticosteroids, Immunotherapy & Vaccines

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1. Report Overview
1. Report Overview
1.1 Global Allergic Rhinitis Drugs Market Overview
1.2 Global Allergic Rhinitis Drugs Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2. Introduction to Allergic Rhinitis
2.1 The Pharmaceutical Industry: a Very Brief Overview
2.2 A Brief Overview of Allergy
2.3 Allergic Rhinitis
2.3.1 The Global Prevalence of Allergic Rhinitis
2.3.2 Pathophysiology of Allergic Rhinitis: IgEs and Mast Cells
2.3.3 Symptoms of Allergic Rhinitis
2.3.4 Classification of Allergic Rhinitis
2.3.4.1 Non-Allergic Rhinitis and Mixed Rhinitis
2.3.5 Seasonal Allergic Rhinitis (Hay Fever)
2.3.6 Perennial Allergic Rhinitis
2.3.7 Diagnosis of Allergic Rhinitis
2.4 Treatment of Allergic Rhinitis
2.4.1 Antihistamines
2.4.1.1 First-Generation Antihistamines
2.4.1.2 Second- and Third-Generation Antihistamines
2.4.2 Corticosteroids
2.4.2.1 First-, Second- and Third-Generation Intranasal Corticosteroids
2.4.2.2 Combination Drug Products
2.4.3 Leukotriene Receptor Antagonists
2.4.4 Cromolyn (cromoglicic acid)
2.4.5 Decongestants
2.4.6 Saline Nasal Sprays
2.4.7 Immunotherapy and Vaccines
2.5 Phases of Clinical Trials
2.6 Scope of this Report
2.7 Currency Exchange Rates in This Report

3. Allergic Rhinitis Drugs: World Market 2014-2024
3.1 The World Allergic Rhinitis Drugs Market in 2013
3.1.1 Leading Allergic Rhinitis Drugs
3.1.2 Leading Companies in the Allergic Rhinitis Drugs Market
3.2 World Allergic Rhinitis Drugs Market: Sales Forecast 2014-2024
3.3 Oral Antihistamines Lead the World Allergic Rhinitis Drugs Market
3.4 How Will Segmental Market Shares Change to 2024?
3.5 World Allergic Rhinitis Drugs Market: Drivers and Restraints 2014-2024

4. Leading National Allergic Rhinitis Drugs Markets 2014-2024
4.1 Geographical Breakdown of the World Allergic Rhinitis Drugs Market
4.2 World Allergic Rhinitis Drugs Market: National Markets Forecast 2014-2024
4.2.1 How Will National Market Shares Change to 2024?
4.3 The US Allergic Rhinitis Drugs Market 2014-2024
4.3.1 US Allergic Rhinitis Drugs Market Forecast 2014-2024
4.3.2 US Allergic Rhinitis Drugs Market: Trends and Developments
4.3.2.1 Rx-to-OTC Switching of Intranasal Corticosteroids
4.3.2.2 Affordable Care Act: Expanding Medicare Coverage
4.4 Chinese Allergic Rhinitis Drugs Market 2014-2024
4.4.1 Chinese Allergic Rhinitis Drugs Market Forecast 2014-2024
4.4.2 Chinese Allergic Rhinitis Drugs Market: Trends and Developments
4.4.2.1 Air Pollution Associated With Increasing Prevalence
4.4.2.2 Expansion of Healthcare Coverage and Reimbursement
4.5 Japanese Allergic Rhinitis Drugs Market 2014-2024
4.5.1 Japanese Allergic Rhinitis Drugs Market Forecast 2014-2024
4.5.2 Japanese Allergic Rhinitis Drugs Market: Trends and Developments
4.5.2.1 Cedar Reforestation and the Hay Fever Epidemic
4.5.2.2 Generic Penetration to Reach 60% by 2018?
4.5.2.3 Genetically Modified Rice as Immunotherapy
4.6 EU5 Allergic Rhinitis Drugs Market 2014-2024
4.6.1 German Allergic Rhinitis Drugs Market Forecast 2014-2024
4.6.2 French Allergic Rhinitis Drugs Market Forecast 2014-2024
4.6.3 UK Allergic Rhinitis Drugs Market Forecast 2014-2024
4.6.4 Italian Allergic Rhinitis Drugs Market Forecast 2014-2024
4.6.5 Spanish Allergic Rhinitis Drugs Market Forecast 2014-2024
4.6.6 EU5 Allergic Rhinitis Drugs Market: Trends and Developments
4.6.6.1 Germany: Reform of AMNOG Pharmaceutical Rebate Law
4.6.6.2 France: Social Security Finance Bill 2014
4.6.6.3 UK: Increasing Burden of Allergy
4.6.6.4 Italy: Austerity Measures Limiting Growth
4.6.6.5 Spain: The Start of Recovery in the Spanish Economy
4.7 Russian Allergic Rhinitis Drugs Market 2014-2024
4.7.1 Russian Allergic Rhinitis Drugs Market Forecast 2014-2024
4.7.2 Russian Allergic Rhinitis Drugs Market: Trends and Developments
4.7.2.1 Pharma2020 and the Russian Pharmaceutical Industry
4.8 Indian Allergic Rhinitis Drugs Market 2014-2024
4.8.1 Indian Allergic Rhinitis Drugs Market Forecast 2014-2024
4.8.2 Indian Allergic Rhinitis Drugs Market: Trends and Developments
4.8.2.1 Drug Prices Control Order 2013
4.8.2.2 Expansion of Healthcare Provision
4.9 Brazilian Allergic Rhinitis Drugs Market 2014-2024
4.9.1 Brazilian Allergic Rhinitis Drugs Market Forecast 2014-2024
4.9.2 Brazilian Allergic Rhinitis Drugs Market: Trends and Developments
4.9.2.1 Increasing Access to Medicines
4.10 Mexican Allergic Rhinitis Drugs Market 2014-2024
4.10.1 Mexican Allergic Rhinitis Drugs Market Forecast 2014-2024
4.10.2 Mexican Allergic Rhinitis Drugs Market: Trends and Developments
4.10.2.1 Seguro Popular: Mexican Healthcare Reform

5. Oral Antihistamines Market 2014-2024
5.1 Oral Antihistamines: A Market in Decline
5.2 Leading Oral Antihistamines in 2013
5.3 Oral Antihistamines: Market Forecast 2014-2024
5.4 Market Share of Leading Oral Antihistamines to 2024
5.5 Oral Antihistamines: Trends and Developments
5.5.1 Patent Expiry and Generic Competition
5.5.2 The Rx-to-OTC Rush
5.5.3 Combination Therapy with Intranasal Corticosteroids
5.6 Allegra/Allegra-D/Allegra OTC (fexofenadine, Sanofi)
5.6.1 Allegra/Allegra OTC: Sales Forecast 2014-2024
5.7 Zyrtec/Zyrtec D (cetirizine, Johnson & Johnson/UCB/GSK)
5.7.1 Zyrtec/Zyrtec D: Sales Forecast 2014-2024
5.8 Claritin/Claritin OTC (loratadine, Merck & Co.)
5.8.1 Claritin/Claritin OTC: Sales Forecast 2014-2024
5.9 Xyzal (levocetirizine, Sanofi/UCB/GSK)
5.9.1 Xyzal: Sales Forecast 2014-2024
5.10 Allelock (olopatadine, Kyowa Hakko Kirin)
5.10.1 Allelock: Sales Forecast 2014-2024
5.11 Clarinex (desloratadine, Merck & Co.)
5.11.1 Clarinex: Sales Forecast 2014-2024
5.12 Talion (bepotastine, Mitsubishi Tanabe)
5.12.1 Talion: Sales Forecast 2014-2024
5.13 Ebastel (ebastine, Almirall/Takeda/Dainippon Sumitomo)
5.13.1 Ebastel: Sales Forecast 2014-2024
5.14 Other Oral Antihistamines

6. Intranasal Corticosteroids Market 2014-2024
6.1 Intranasal Corticosteroids: First-line for Allergic Rhinitis
6.2 Leading Intranasal Corticosteroids in 2013
6.3 Intranasal Corticosteroids: Market Forecast by Value, 2014-2024
6.4 Intranasal Corticosteroids: Market Forecast by Volume, 2014-2024
6.5 Market Share of Leading Intranasal Corticosteroids to 2024
6.6 Intranasal Corticosteroids: Trends and Developments
6.6.1 Nasonex Patent Expiry in 2014
6.6.2 Nasacort AQ Switched to OTC
6.7 Nasonex (mometasone, Merck)
6.7.1 Nasonex: Sales Forecast by Value, 2014-2024)
6.7.2 Nasonex: Sales Forecast by Volume, 2014-2024)
6.8 Avamys/Veramyst (fluticasone furoate, GSK)
6.8.1 Avamys/Veramyst: Sales Forecast by Value, 2014-2024)
6.8.2 Avamys/Veramyst: Sales Forecast by Volume, 2014-2024)
6.9 Flixonase/Flonase (fluticasone propionate, GSK)
6.9.1 Flixonase/Flonase: Sales Forecast by Value, 2014-2024)
6.9.2 Flixonase/Flonase: Sales Forecast by Volume, 2014-2024)
6.10 Rhinocort (budesonide, AstraZeneca)
6.10.1 Rhinocort: Sales Forecast by Value, 2014-2024)
6.10.2 Rhinocort: Sales Forecast by Volume, 2014-2024)
6.11 Omnaris (ciclesonide, Dainippon Sumitomo/Takeda)
6.11.1 Omnaris: Sales Forecast by Value, 2014-2024)
6.11.2 Omnaris: Sales Forecast by Volume, 2014-2024)
6.12 Beconase/Beconase AQ (beclometasone, GSK/Omega Pharma)
6.12.1 Beconase/Beconase AQ: Sales Forecast by Value, 2014-2024)
6.12.2 Beconase/Beconase AQ: Sales Forecast by Volume, 2014-2024)
6.13 Nasacort (triamcinolone, Sanofi)
6.13.1 Nasacort: Sales Forecast by Value, 2014-2024)
6.13.2 Nasacort: Sales Forecast by Volume, 2014-2024)
6.14 QNasl (beclometasone, Teva)
6.14.1 QNasl: Sales Forecast by Value, 2014-2024)
6.14.2 QNasl: Sales Forecast by Volume, 2014-2024)
6.15 Zetonna (ciclesonide, Dainippon Sumitomo)
6.15.1 Zetonna: Sales Forecast by Value, 2014-2024)
6.15.2 Zetonna: Sales Forecast by Volume, 2014-2024)
6.16 Generic Intranasal Corticosteroids
6.16.1 Generic Intranasal Beclometasone
6.16.1.1 Generic Intranasal Beclometasone: Sales Forecast by Value, 2014-2024
6.16.1.2 Generic Intranasal Beclometasone: Sales Forecast by Volume, 2014-2024
6.16.2 Generic Intranasal Budesonide
6.16.2.1 Generic Intranasal Budesonide: Sales Forecast by Value, 2014-2024
6.16.2.2 Generic Intranasal Budesonide: Sales Forecast by Volume, 2014-2024
6.16.3 Generic Intranasal Flunisolide
6.16.3.1 Generic Intranasal Flunisolide: Sales Forecast by Value, 2014-2024
6.16.3.2 Generic Intranasal Flunisolide: Sales Forecast by Volume, 2014-2024
6.16.4 Generic Intranasal Fluticasone
6.16.4.1 Generic Intranasal Fluticasone: Sales Forecast by Value, 2014-2024
6.16.4.2 Generic Intranasal Fluticasone: Sales Forecast by Volume, 2014-2024
6.16.5 Generic Intranasal Mometasone
6.16.5.1 Generic Intranasal Mometasone: Sales Forecast by Value, 2014-2024
6.16.5.2 Generic Intranasal Mometasone: Sales Forecast by Volume, 2014-2024
6.16.6 Generic Intranasal Triamcinolone
6.16.6.1 Generic Intranasal Triamcinolone: Sales Forecast by Value, 2014-2024
6.16.6.2 Generic Intranasal Triamcinolone: Sales Forecast by Volume, 2014-2024

7. Intranasal Antihistamines Market 2014-2024
7.1 Intranasal Antihistamines: A Niche Segment
7.2 Leading Intranasal Antihistamines in 2013
7.3 Intranasal Antihistamines: Market Forecast by Value, 2014-2024
7.4 Intranasal Antihistamines: Market Forecast by Volume, 2014-2024
7.5 Market Share of Leading Intranasal Antihistamines to 2024
7.6 Intranasal Antihistamines: Trends and Developments
7.6.1 Azelastine versus Olopatadine
7.6.2 Intranasal Combination Products
7.7 Astepro (azelastine, Meda)
7.7.1 Astepro: Sales Forecast 2014-2024
7.8 Patanase (olopatadine, Novartis)
7.8.1 Patanase: Sales Forecast 2014-2024
7.9 Astelin (azelastine, Meda)
7.9.1 Astelin: Sales Forecast 2014-2024
7.10 Dymista (azelastine/fluticasone, Meda)
7.10.1 Dymista: Sales Forecast 2014-2024
7.11 Generic Intranasal Azelastine
7.11.1 Generic Intranasal Azelastine: Sales Forecast by Value, 2014-2024
7.11.1 Generic Intranasal Azelastine: Sales Forecast by Volume, 2014-2024
7.12 Generic Intranasal Olopatadine
7.12.1 Generic Intranasal Azelastine: Sales Forecast by Value, 2014-2024
7.12.2 Generic Intranasal Azelastine: Sales Forecast by Volume, 2014-2024

8. Immunotherapy and Vaccines Market 2014-2024
8.1 Immunotherapy: Set for Rapid Expansion
8.2 Leading Immunotherapy Products in 2013
8.3 Immunotherapy: Market Forecast 2014-2024
8.4 Market Share of Leading Immunotherapy Products to 2024
8.5 Immunotherapy: Leading Companies
8.6 Immunotherapy: Trends and Developments
8.6.1 Subcutaneous and Sublingual Immunotherapy
8.6.2 Expansion into the US Market
8.6.3 Standardisation of Immunotherapy Products
8.6.4 Immunotherapy as a Preventative Treatment
8.7 Staloral (Grass pollen allergen extract, Stallergenes)
8.7.1 Staloral: Sales Forecast 2014-2024
8.8 Alutard SQ (Grass pollen allergen extract, ALK-Abelló)
8.8.1 Alutard SQ: Sales Forecast 2014-2024
8.9 Grazax/Grastek (Timothy grass pollen allergen extract, ALK-Abelló/Merck)
8.9.1 Grazax/Grastek: Sales Forecast 2014-2024
8.10 Oralair (Grass pollen allergen extract, Stallergenes/Greer)
8.10.1 Oralair: Sales Forecast 2014-2024
8.11 Ragwitek (Short ragweed pollen allergen extract, Merck)
8.11.1 Ragwitek: Sales Forecast 2014-2024

9. Leading Companies in the Allergic Rhinitis Drugs Market in 2014
9.1 Allergic Rhinitis Drugs: Merck & Co. Leads in a Fragmented Market
9.2 ALK-Abelló
9.2.1 ALK-Abelló: Allergic Rhinitis Drugs
9.2.2 ALK-Abelló: Allergic Rhinitis Sales Forecast 2014-2024
9.2.3 ALK-Abelló: Products in Development
9.2.4 ALK-Abelló: Recent Developments
9.2.4.1 ALK Collaborates with EddingPharm to Boost China Sales
9.2.4.2 Jext Product Recall
9.3 GSK
9.3.1 GSK: Allergic Rhinitis Drugs
9.3.2 GSK: Allergic Rhinitis Sales Forecast 2014-2024
9.3.3 GSK: Products in Development
9.3.4 GSK: Recent Developments
9.3.4.1 GSK Divestment of OTC Products
9.3.4.2 GSK Asset Swap with Novartis to Restructure Consumer Health
9.4 Johnson & Johnson
9.4.1 Johnson & Johnson: Allergic Rhinitis Drugs
9.4.2 Johnson & Johnson: Allergic Rhinitis Sales Forecast 2014-2024
9.4.3 Johnson & Johnson: Recent Developments
9.4.3.1 Launch of Zyrtec Dissolve Tabs
9.4.3.2 Manufacturing Recalls at McNeil Consumer Healthcare
9.5 Kyowa Hakko Kirin
9.5.1 Kyowa Hakko Kirin: Allergic Rhinitis Drugs
9.5.2 Kyowa Hakko Kirin: Allergic Rhinitis Sales Forecast 2014-2024
9.6 Merck & Co.
9.6.1 Merck: Allergic Rhinitis Drugs
9.6.2 Merck: Allergic Rhinitis Sales Forecast 2014-2024
9.6.3 Merck: Products in Development
9.6.4 Merck: Recent Developments
9.6.4.1 Bayer Acquires Merck’s Consumer Health Business
9.6.4.2 FDA Rejects Singulair OTC Switch
9.7 Sanofi
9.7.1 Sanofi: Allergic Rhinitis Drugs
9.7.2 Sanofi: Allergic Rhinitis Sales Forecast 2014-2024
9.8 Stallergenes
9.8.1 Stallergenes: Allergic Rhinitis Drugs
9.8.2 Stallergenes: Allergic Rhinitis Sales Forecast 2014-2024
9.8.3 Stallergenes: Products in Development
9.8.4 Stallergenes: Recent Developments
9.8.4.1 Stallergenes Acquires Argentinean Company Alergo Pharma
9.8.4.2 Greer launches Oralair in the US
9.9 UCB
9.9.1 UCB: Allergic Rhinitis Drugs
9.9.2 UCB: Allergic Rhinitis Sales Forecast 2014-2024
9.10 Other Leading Companies

10. Allergic Rhinitis Drugs Pipeline Analysis 2014-2024
10.1 Trends and Developments in the Allergic Rhinitis Pipeline
10.2 The Oral Antihistamine Pipeline
10.2.1 Talion (bepotastine, Mitsubishi Tanabe)
10.2.2 ZPL-3893787 (histamine H4R antagonist, Ziarco Pharma)
10.2.3 ZPL-868087 (oral histamine H3R antagonist, Ziarco Pharma)
10.3 The Intranasal Corticosteroids Pipeline
10.3.1 APC-3000 (HFA inhaled corticosteroid, Adamis Pharmaceuticals)
10.3.2 S0597 (topical glucocorticoid, Sun Pharma)
10.3.3 TBS-6 (Trimel Pharmaceuticals)
10.4 The Immunotherapy Pipeline
10.4.1 Actair (house dust mite SLIT, Stallergenes/Shionogi)
10.4.2 AllerT (subcutaneous birch pollen immunotherapy, Anergis)
10.4.3 Cat-SPIRE and other -SPIRE Therapies (synthetic peptide immunoregulatory epitopes, Circassia)
10.4.4 Depigoid Birch 5000 (birch pollen allergen extract, Leti Pharma)
10.4.5 House Dust Mite SLIT-Tablet (MK-8237, ALK-Abelló/Merck/Torii)
10.4.6 Pollinex Quattro (subcutaneous immunotherapies, Allergy Therapeutics)
10.4.7 gp-ASIT+ (grass pollen allergen fragments, Biotech Tools)
10.4.8 Betula verrucosa (Bet v) 1 allergen (Stallergenes)
10.5 The Pipeline for Other Allergic Rhinitis Drugs
10.5.1 eN-Lac (Lactobacillus paracasei GMNL-32, GenMont Biotech)
10.5.2 S-555739 (prostaglandin D2 receptor antagonist, Shionogi)
10.5.3 DSP-3025/AZD-8848 (toll-like receptor 7 agonist, Dainippon Sumitomo/AstraZeneca)
10.5.4 GSK2245035 (toll-like receptor 7 agonist, GSK)
10.5.5 HP-3060 (transdermal long-acting tape, Hisamitsu)
10.5.6 MRX-4 (anti-inflammatory agent, Celsus Therapeutics)
10.5.7 OC459 (Oxagen/Atopix Therapeutics/Eleventa)
10.5.8 ONO-4053 (prostaglandin D2 receptor antagonist, Ono Pharmaceutical)
10.5.9 WF10 (tetrachlorodecaoxygen chlorite matrix, Nuvo Research)
10.5.10 RPL554 (PDE-3/PDE-4 antagonist, Verona Pharma)
10.5.11 VTX-1463 (toll-like receptor 8 agonist, VentiRx)

11. Qualitative Analysis of the Allergic Rhinitis Drugs Market 2014-2024
11.1 SWOT Analysis of the Allergic Rhinitis Drugs Market
11.2 Strengths
11.2.1 High Unmet Clinical Need
11.2.2 Established Role of Allergic Rhinitis Drugs in Treatment
11.2.3 High Profile Disease Encouraging Improving Healthcare Provision
11.2.4 Increasing Consumer Demand
11.3 Weaknesses
11.3.1 Increasing Generic Penetration
11.3.2 Patient Dissatisfaction with Intranasal Corticosteroids
11.3.3 Limited Allergic Rhinitis Drugs Pipeline
11.4 Opportunities
11.4.1 The Rise of Immunotherapy
11.4.2 Higher Growth in Emerging Markets
11.4.3 Combination Drug Products
11.4.4 Rx-to-OTC Switching
11.5 Threats
11.5.1 Patent Expiry
11.5.2 Cost-Containment
11.5.3 Rising API and Manufacturing Costs
11.6 Porter’s Five Forces Analysis of the Allergic Rhinitis Drugs Market
11.6.1 Rivalry Among Competitors [High]
11.6.2 Threat of New Entrants [Low]
11.6.3 Power of Suppliers [Low]
11.6.4 Power of Buyers [Medium]
11.6.5 Threat of Substitutes [Low]

12. Research Interviews
12.1 Interview with Maureen Jenkins, Director of Clinical Services for Allergy UK, Sidcup, Kent, UK
12.1.1 Allergic Rhinitis in the UK
12.1.2 Allergic Rhinitis Treatments
12.1.3 Opportunities for Manufacturers
12.2 Interview with Kimihiro Okubo, Chairman and Professor, Department of Otolaryngology, Nippon Medical School, Tokyo, Japan
12.2.1 Allergic Rhinitis in Japan
12.3 Interview with Jonathan Bernstein, Chairman and Professor, Department of Internal Medicine, University of Cincinnati, Ohio, US
12.3.1 Allergic Rhinitis in the US
12.3.2 Nasacort AQ and OTC Nasal Sprays
12.3.3 Dymista and Combination Therapies
12.3.4 Trends and Developments in Allergic Rhinitis
12.4 Interview with Tonya Winders, President and CEO, Allergy & Asthma Network Mothers of Asthmatics, Virginia, US
12.4.1 Allergic Rhinitis in the US
12.4.2 Allergic Rhinitis Treatments
12.4.3 US Healthcare Reform and Intranasal Drugs
12.5 Interview with Allergy Medical UK, Weybridge, UK
12.5.1 Allergic Rhinitis Treatments

13. Conclusions
13.1 Allergic Rhinitis Drugs: A Mature Market
13.2 The World Allergic Rhinitis Market in 2013
13.2.1 Current Leading Allergic Rhinitis Segments
13.2.2 Leading Allergic Rhinitis Products
13.2.3 Leading Allergic Rhinitis Drugs Companies
13.2.4 Leading National Markets
13.3 World Allergic Rhinitis Drugs Market Forecast 2014-2024
13.4 Allergic Rhinitis Late-Stage Pipeline
13.5 The Future of the Allergic Rhinitis Drugs Market?


【レポート販売概要】

■ タイトル:世界のアレルギー性鼻炎治療薬市場予測:抗ヒスタミン剤、コルチコステロイド、免疫治療、ワクチン
■ 英文:ALLERGIC RHINITIS DRUGS MARKET FORECAST 2014-2024
Future Prospects for Companies in Antihistamines, Corticosteroids, Immunotherapy & Vaccines
■ 発行日:2014年8月
■ 調査会社:visiongain
■ 商品コード:VISG409043
■ 調査対象地域:グローバル
  • T-Cell Lymphomas:グローバル臨床試験動向(2014年上半期)
    T-Cell Lymphomas Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “T-Cell Lymphomas Global Clinical Trials Review, H1, 2014" provides data on the T-Cell Lymphomas clinical trial scenario. This report provides elemental information and data relating to the clinical trials on T-Cell Lymphomas. It includes an overview of the trial numbers and their recruitment statu …
  • 産業向け省エネサービスの世界市場2016-2020
    About Industrial Energy Efficiency Services Energy-efficiency services provide a promising opportunity to the industrial sector to achieve greenhouse gas emissions reductions. ESCOs are already operating successfully in developed countries, primarily in North America and Western Europe. Despite gaining some moderate success in countries such as South Korea and Brazil, ESCOs are yet to gain a signi …
  • 世界の自動車用アクチュエータ市場2015
    The Global Automotive Actuators Industry Report 2015 is a professional and in-depth study on the current state of the Automotive Actuators industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Automotive Actuators market analysis is provided for the international markets including development trends, com …
  • 2012年テレコム市場:トレンド、ビジネスイシュー、技術、アプリケーション(Top Telecom 2012: Trends, Business Issues, Technologies, and Applications)
    The telecommunications market represents a large ecosystem with multiple players, solutions, applications, technologies and relationships in a multi-billion dollar industry. It is often daunting to understand the technical and market dynamics and plan business accordingly. This report provides the reader with an understanding of leading trends, issues, challenges, and opportunities with telecommun …
  • 世界のエネルギー管理情報システム市場動向(2014~2018)
    TechNavio's analysts forecast the Global Energy Management Information System market to grow at a CAGR of 5.07 percent over the period 2013-2018. One of the key factors contributing to this market growth is the emergence of the Process Automation industry. The Global Energy Management Information System market has also been witnessing the increase in the usage of computer-based systems in the Ener …
  • 紙コップ・紙容器の世界市場2017-2021
    ABSTRACTAbout Paper Cups and Containers Paper cups are usually coated with PE, which provides stability and heat resistance. However, these PE-coated paper cups are hard to recycle and do not decompose easily, which results in large amounts of paper cups piling up in landfills. Disposable containers are primarily made of paperboard, which is a little thicker than paper. These containers are usuall …
  • OJSC Rosneft Oil Company:石油・ガスバリューチェーン分析レポート2013
    OJSC Rosneft Oil Company Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "OJSC Rosneft Oil Company" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “OJSC Rosneft Oil Company”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The …
  • 外国為替(FX)の世界市場:通貨スワップ、アウトライト取引、FXスワップ、FXオプション
    About the Foreign Exchange Market Foreign exchange markets remained robust during the 2007 financial crisis. The advent of electronic platforms has significantly boosted day-to-day trading volumes, which generates higher levels of market returns, that have remained uncorrelated compared to the different trading markets across the world. Widespread electronic trading permits anonymous market practi …
  • 世界のオメガ3市場:種類別(DHA、EPA、およびALA)、用途別(栄養補助食品、機能性食品および飲料、医薬品、乳児用調製粉乳、ペットフードおよび飼料)、由来別(海洋および植物)、地域別
    “The omega-3 market is projected to grow at a CAGR of 13.1% from 2019 to 2025.” The global omega-3 market size is estimated to be valued at USD 4.1 billion in 2019 and is projected to reach USD 8.5 billion by 2025, recording a CAGR of 13.1%. Consumer awareness regarding the health benefits of omega-3 and an increase in application profiling and existing applications finding new markets are some of …
  • 電子タバコの世界市場2016-2020
    About the E-Cigarette Market An e-cigarette, also known as an e-vaping device, personal vaporizer, or electronic nicotine delivery system contains a heating element that vaporizes liquid nicotine or a flavored liquid. These liquids, called e-liquids, are available in more than 4,000 flavors, with vendors adding more than 300 flavors every month. One e-cigarette is equal to 6-8 tobacco cigarettes. …
  • 指関節用インプラントの世界市場2019-2023
    Global Digit Joint Implants Market: About this market Digit joint implants are medical devices used to replace the damaged or diseased bone and joints of body parts. Technavio’s digit joint implants market analysis considers sales from MCP and PIP joint implants, Trapeziometacarpal joint implants, Toe implants, Others. Our analysis also considers the sales of digit joint implants in Asia, Europe, …
  • 加入者データ管理市場(The Subscriber Data Management (SDM) Market: 2012 – 2016)
    Subscriber data is a principal asset held by network carriers. Subscriber Data Management (SDM) allows carriers to consolidate and manage their cross domain subscriber data encompassing access preferences, authentication, services, identities, location, and presence into unified data repositories. Besides enabling considerable OPEX reductions and allowing carriers to deliver more personalised serv …
  • 世界半導体マーケットプレイス:産業、成長要因、予測(Global Semiconductor Marketplace: Industry Verticals, Growth Drivers, and Forecast 2012 – 2017)
    Semiconductor technologies continue to evolve and amaze even those that previously forecasted aggressive growth. New materials, new structures, new manufacturing tools, and new advancements in modeling and simulation form a breeding ground for novel high performance electronic and photonic devices. High costs, long manufacturing cycles, and enormous increase in computing power are behind recent ra …
  • 溶融塩熱エネルギー貯蔵の世界市場2019-2023
    About this market In the commercial and industrial (C&I) sectors, downtime caused by power outages leads to huge losses for the companies. For commercial and industrial sectors, such as the manufacturing, engineering and construction, pharmaceutical and healthcare, oil and gas, industrial farming, mining, energy, aerospace, petrochemical, warehousing, and distribution sectors, power backup is cruc …
  • ディーゼルエンジン用コモンレール噴射システムの世界市場
    About Diesel Common Rail Injection System Common rail injection represents the most advanced technology in the diesel engine fuel injection system. In this system, pressure generation and injection systems are kept separate. This allows fuel to be constantly available in a rail with the required pressure for injection. High-pressure pumps compress the fuel, which is fed to the engine cylinders thr …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。